losulazine hydrochloride has been researched along with desipramine in 1 studies
*Desipramine: A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors. [MeSH]
*Desipramine: A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| DeGraaf, GL; Pals, DT | 1 |
1 other study(ies) available for losulazine hydrochloride and desipramine
| Article | Year |
|---|---|
Cardiovascular effects of losulazine hydrochloride, a peripheral norepinephrine-depleting agent, in nonhuman primates.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Cardiac Output; Chlorisondamine; Desipramine; Dose-Response Relationship, Drug; Guanethidine; Heart Rate; Hemodynamics; Hypotension, Orthostatic; Macaca fascicularis; Male; Nitroprusside; Norepinephrine; Piperazines; Reserpine; Vascular Resistance | 1985 |